Form 8-K - Current report:
SEC Accession No. 0001193125-24-159748
Filing Date
2024-06-12
Accepted
2024-06-12 12:28:02
Documents
13
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d871241d8k.htm   iXBRL 8-K 31973
  Complete submission text file 0001193125-24-159748.txt   157404

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA annx-20240605.xsd EX-101.SCH 2847
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20240605_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20240605_pre.xml EX-101.PRE 11708
16 EXTRACTED XBRL INSTANCE DOCUMENT d871241d8k_htm.xml XML 3768
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 241037918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)